Explore more publications!
Korean distributor agreement with DK Healthcare in South Korea
Ilham Aliyev attended inauguration of pharmaceutical production facility

Ilham Aliyev attended inauguration of pharmaceutical production facility

VA Pharmacy Residency Program: From student to specialist

VA Pharmacy Residency Program: From student to specialist

Creative Diagnostics Expands Portfolio of Products for ADME Studies to Accelerate Drug Development Success
Providence Saint John’s Earns Magnet Recognition, The Gold Standard in Nursing Excellence
Biodexa Activates First European Site for Registrational Phase 3 Serenta Trial in FAP
Inside a Saudi Hospital’s Neuroscience Ward, a Quiet Revolution Unfolds
Medical Writing Market to Reach USD 10.67 Billion by 2032 | Size, Share, Trends, Forecast, Demand & Competitive Analysis
Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
Schizophrenia & Psychosis Action Alliance Unveils Housing Toolkit to Help Those with Serious Mental Illness Find a Home
Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME’s America’s Growth Leaders of 2026
Foxwynd Foundation Renews Partnership for Project Sweet Peas’ NICU Families
ROSEN, LEADING INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
Dr. Zachary Solomon Launches the Medical Tech Grant to Advance Innovation in Healthcare and Technology
Why Gratitude Can Be a Powerful Medicine

Why Gratitude Can Be a Powerful Medicine

CodaPet expands compassionate in-home pet euthanasia services to Frederick, MD.
Telix Pharmaceuticals Limited (TLX) Faces Securities Class Action Amid SEC Subpoena, Complete Response Letter -- Hagens Berman
Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions